ID   ANS1B_RAT               Reviewed;        1260 AA.
AC   P0C6S7;
DT   08-APR-2008, integrated into UniProtKB/Swiss-Prot.
DT   08-APR-2008, sequence version 1.
DT   02-OCT-2024, entry version 110.
DE   RecName: Full=Ankyrin repeat and sterile alpha motif domain-containing protein 1B;
DE   AltName: Full=Amyloid-beta protein intracellular domain-associated protein 1;
DE            Short=AIDA-1;
DE   AltName: Full=E2A-PBX1-associated protein;
DE            Short=EB-1;
GN   Name=Anks1b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, INTERACTION WITH
RP   DLG4, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF
RP   935-HIS--ARG-938, AND PROTEOLYTIC CLEAVAGE.
RC   TISSUE=Brain;
RX   PubMed=17334360; DOI=10.1038/nn1867;
RA   Jordan B.A., Fernholz B.D., Khatri L., Ziff E.B.;
RT   "Activity-dependent AIDA-1 nuclear signaling regulates nucleolar numbers
RT   and protein synthesis in neurons.";
RL   Nat. Neurosci. 10:427-435(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY (ISOFORM 3), AND SUBCELLULAR LOCATION.
RX   PubMed=15169875; DOI=10.1074/mcp.m400045-mcp200;
RA   Jordan B.A., Fernholz B.D., Boussac M., Xu C., Grigorean G., Ziff E.B.,
RA   Neubert T.A.;
RT   "Identification and verification of novel rodent postsynaptic density
RT   proteins.";
RL   Mol. Cell. Proteomics 3:857-871(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-365; THR-773 AND SER-775, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Isoform 2 may participate in the regulation of nucleoplasmic
CC       coilin protein interactions in neuronal and transformed cells.
CC       {ECO:0000269|PubMed:17334360}.
CC   -!- FUNCTION: Isoform 3 can regulate global protein synthesis by altering
CC       nucleolar numbers. {ECO:0000269|PubMed:17334360}.
CC   -!- SUBUNIT: Interacts with EPHA8 (By similarity). Isoform 2 interacts with
CC       COIL. Isoform 3 interacts with DLG4. {ECO:0000250,
CC       ECO:0000269|PubMed:17334360}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Postsynaptic density. Cell
CC       projection, dendritic spine. Nucleus. Nucleus, Cajal body. Note=The
CC       synaptic localization requires DLG4 interaction. Translocation to the
CC       nucleus in response to stimulation of NMDA receptors (NMDARs) in a
CC       calcium-independent manner.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P0C6S7-1; Sequence=Displayed;
CC       Name=2; Synonyms=AIDA-1e;
CC         IsoId=P0C6S7-2; Sequence=VSP_032720, VSP_032721, VSP_032723;
CC       Name=3; Synonyms=AIDA-1d;
CC         IsoId=P0C6S7-3; Sequence=VSP_032720, VSP_032721, VSP_032722;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is brain specific and highly enriched in
CC       the postsynaptic densities (PSDs), especially in cortical, striatal and
CC       hippocampal PSDs. {ECO:0000269|PubMed:17334360}.
CC   -!- PTM: Nuclear translocation of isoform 3 requires an NMDAR-dependent
CC       proteolytic cleavage. A 35 kDa N-terminal form shuttles to the nucleus.
CC       {ECO:0000269|PubMed:17334360}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR03061338; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03058184; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03058315; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03059811; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03060233; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03056177; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03057703; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03056626; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03056332; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03055414; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03055479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03055359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AABR03058062; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_006241311.1; XM_006241249.3.
DR   AlphaFoldDB; P0C6S7; -.
DR   SMR; P0C6S7; -.
DR   BioGRID; 260815; 2.
DR   IntAct; P0C6S7; 1.
DR   MINT; P0C6S7; -.
DR   STRING; 10116.ENSRNOP00000056036; -.
DR   iPTMnet; P0C6S7; -.
DR   PhosphoSitePlus; P0C6S7; -.
DR   SwissPalm; P0C6S7; -.
DR   PaxDb; 10116-ENSRNOP00000056036; -.
DR   Ensembl; ENSRNOT00000119672.1; ENSRNOP00000083437.1; ENSRNOG00000024870.8. [P0C6S7-2]
DR   AGR; RGD:1565556; -.
DR   CTD; 56899; -.
DR   RGD; 1565556; Anks1b.
DR   eggNOG; KOG0507; Eukaryota.
DR   GeneTree; ENSGT00940000154572; -.
DR   InParanoid; P0C6S7; -.
DR   OrthoDB; 25046at2759; -.
DR   PhylomeDB; P0C6S7; -.
DR   PRO; PR:P0C6S7; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   GO; GO:0015030; C:Cajal body; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IDA:SynGO.
DR   GO; GO:0014069; C:postsynaptic density; IDA:SynGO.
DR   GO; GO:0099092; C:postsynaptic density, intracellular component; IDA:SynGO.
DR   GO; GO:0099523; C:presynaptic cytosol; IDA:SynGO.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0046875; F:ephrin receptor binding; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0099527; P:postsynapse to nucleus signaling pathway; IDA:SynGO.
DR   GO; GO:0097120; P:receptor localization to synapse; IMP:MGI.
DR   GO; GO:1900383; P:regulation of synaptic plasticity by receptor localization to synapse; ISO:RGD.
DR   CDD; cd01274; PTB_Anks; 1.
DR   CDD; cd09499; SAM_AIDA1AB-like_repeat1; 1.
DR   CDD; cd09500; SAM_AIDA1AB-like_repeat2; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 2.
DR   InterPro; IPR033635; ANKS1/Caskin.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR006020; PTB/PI_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR041880; SAM_ANKS1_repeat1.
DR   InterPro; IPR041882; SAM_ANKS1_repeat2.
DR   PANTHER; PTHR24174; ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 1; 1.
DR   PANTHER; PTHR24174:SF3; ANKYRIN REPEAT AND STERILE ALPHA MOTIF DOMAIN-CONTAINING PROTEIN 1B; 1.
DR   Pfam; PF12796; Ank_2; 3.
DR   Pfam; PF00640; PID; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 6.
DR   SMART; SM00462; PTB; 1.
DR   SMART; SM00454; SAM; 2.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 2.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 5.
DR   PROSITE; PS01179; PID; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 2.
PE   1: Evidence at protein level;
KW   Alternative splicing; ANK repeat; Cell projection; Cytoplasm; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Synapse.
FT   CHAIN           1..1260
FT                   /note="Ankyrin repeat and sterile alpha motif domain-
FT                   containing protein 1B"
FT                   /id="PRO_0000327261"
FT   REPEAT          2..31
FT                   /note="ANK 1"
FT   REPEAT          58..87
FT                   /note="ANK 2"
FT   REPEAT          91..120
FT                   /note="ANK 3"
FT   REPEAT          127..156
FT                   /note="ANK 4"
FT   REPEAT          160..189
FT                   /note="ANK 5"
FT   REPEAT          193..222
FT                   /note="ANK 6"
FT   REPEAT          225..254
FT                   /note="ANK 7"
FT   DOMAIN          810..876
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          884..949
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          1056..1213
FT                   /note="PID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00148"
FT   REGION          298..326
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          368..402
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          491..513
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          556..642
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          754..778
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          946..989
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1197..1217
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           935..938
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        305..326
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        368..387
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        556..577
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        764..778
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        960..987
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         311
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         315
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         504
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         508
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         739
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         773
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         775
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         901
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         974
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   MOD_RES         1007
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8BIZ1"
FT   VAR_SEQ         1..771
FT                   /note="Missing (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17334360"
FT                   /id="VSP_032720"
FT   VAR_SEQ         772..807
FT                   /note="RTPSFTSEWEEIDKIMNSIDVGINSELEGMNGEATR -> MMWQCHLSAQDY
FT                   RYYPVDGYSLLKRFPLHPLTG (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17334360"
FT                   /id="VSP_032721"
FT   VAR_SEQ         963..1022
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17334360"
FT                   /id="VSP_032723"
FT   VAR_SEQ         1022
FT                   /note="Q -> QSSVCEIWTNQNAGFPFSAIHQVHN (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17334360"
FT                   /id="VSP_032722"
FT   MUTAGEN         935..938
FT                   /note="HRKR->AAAA: Does not shuttle to the nucleus in
FT                   response to NMDA stimulation."
FT                   /evidence="ECO:0000269|PubMed:17334360"
FT   MUTAGEN         1000..1003
FT                   /note="RRRR->AAAA: Shuttles to the nucleus is irrespective
FT                   of NMDA stimulation."
SQ   SEQUENCE   1260 AA;  139207 MW;  C7C71F67C349C50D CRC64;
     MGKDQELLEA ARTGNVALVE KLLSGRKGGI LGGGSGPLPL SNLLSIWRGP NVNCTDSSGY
     TALHHAALNG HKDIVLKLLQ FEASTNVADN KGYFPIHLAA WKGDVEIVKI LIHHGPSHSR
     VNEQNNENET ALHCAAQYGH SEVVAVLLEE LTDPTIRNSK LETPLDLAAL YGRLRVVKMI
     ISAHPNLMSC NTRKHTPLHL AARNGHKAVV QVLLEAGMDV SCQTEKGSAL HEAALFGKVD
     VVRVLLETGI DANIKDSLGR TVLDILKEHP SQKSLQIATL LQDYLEGVGR SVVLEEEHAQ
     EDTAQETRLS SPAQSPSQKT KSETVTGELS KLLDEIKLCQ EKDYSFEDLC HTISDHYLDN
     LSKISEEELG KNGSQSVRTS STINLSPGEV EDEEEDPNSC GPTGLWEALT PCNGCRNLGF
     PMLAQESYPK KRNYPMEIVP SASLDTFPSE NENFLCELVD TAVTKKPCSL EIARAPSPRT
     DNASEVAITA PGTGHHRNSS TGPTPDCSPP SPDTALKNIV KVIRPQPKQR TSIVSSLDFQ
     RMNHNQEYFE ISTSTGCTSF TSSPPVSPPT SSVETTEIKN EGAEHTDDLS QQEDDEPPKE
     YDAGQFAGLL HGSSPACEAP ENPFHLYGKR NQGEDGQEEA SLANSPLPFK QTPIENNPEP
     SVKKIKPKVV SRTIFHKRSH QLENHTIVGT RMSRGGSRNG DQWGVNPGGF VERACTLGRI
     RSLPKALIDM HLSKNVSKSD SDLIAYPSKD KARVNWSKSS TAERSSKDNS ERTPSFTSEW
     EEIDKIMNSI DVGINSELEG MNGEATRPRC PVQTVGQWLE SIGLPQYENH LTANGFDNVQ
     FMGSNVMEDQ DLLEIGILNS GHRQRILQAI QLLPKMRPIG HDGYHPTSVA EWLDSIELGD
     YTKAFLINGY TSMDLLKKIW ELELINVLKI SLIGHRKRIL ASLGDRLHED PPQKPPRSIT
     LREPSGNHTP PQLSPSLSQS TYTTGGSLDV PHIIMQGDAR RRRNENYFDD IPRSKLERQM
     AQTGDWGEPS ITLRPPNEAT ASTPVQYWQH HPEKLIFQSC DYKAFYLGSM LIKELRGTES
     TQDACAKMRA NCQKSTEQMK KVPTIILSVS YKGVKFIDAA NKNIIAEHEI RNISCAAQDP
     EDLSTFAYIT KDLKSNHHYC HVFTAFDVNL AYEIILTLGQ AFEVAYQLAL QARKGGHSST
     LPESFENKPS KPIPKPRVSI RKSVQIDPSE QKTLANLPWI VEPGQEAKRG INTKYETTIF
//
